Neuralign Clinical Study Awarded Best Paper at DVSE Annual Congress
MUNICH – Alyve Medical congratulates Prof. Philipp Moroder and Prof. Laurent Audigé on receiving the award for Best Paper at the D-A-CH Vereinigung für Schulter- und Ellenbogenchirurgie e. V. (German-Austrian-Swiss Society for Shoulder and Elbow Surgery) Annual Congress in Munich.
Alyve Medical Delivers Breakthrough Investor Presentation at Venture Summit West
SAN FRANCISCO – Alyve Medical Inc. recently became one of only 200 companies worldwide to earn a coveted presentation slot at the 10th annual Venture Summit West.
Alyve Medical, Inc. Appoints New CEO
Alyve Medical, Inc. (formerly NCS America, Inc.), a global medical technology company and leader in data-driven joint kinematics tools, and personalized neuromuscular electrical stimulation (NMES) technologies, today announced that Yvonne Bokelman has been appointed its Chief Executive Officer.
NCS America, Inc. Announces Name Change to Alyve Medical, Inc.
NCS America, Inc. a global medical technology company and leader in data-driven joint kinematics tools and personalized neuromuscular electrical stimulation (NMES) technologies, announced today that it is changing its name to Alyve Medical, Inc.
NCS America, Inc. launches the Shoulder Pacemaker™ after receiving FDA clearance
NCS America, Inc. a world leader in developing technology to help diagnose, treat and prevent musculoskeletal injuries, today announced the expansion of their breakthrough product offerings with the FDA clearance of the Shoulder Pacemaker™ and its patented Motion Activated Stimulation (MAS) technology.